标题/作者	年份
Mild or moderate Covid-19 RT Gandhi, JB Lynch, C Del Rio New England Journal of Medicine 383 (18), 1757-1766	2020
Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477	2021
Anosmia in COVID-19: underlying mechanisms and assessment of an olfactory route to brain infection R Butowt, CS von Bartheld The Neuroscientist 27 (6), 582-603	2021
Prevalence of chemosensory dysfunction in COVID-19 patients: a systematic review and meta-analysis reveals significant ethnic differences CS von Bartheld, MM Hagen, R Butowt ACS chemical neuroscience 11 (19), 2944-2961	2020
Self-medication practices during the COVID-19 pandemic among the adult population in Peru: A cross-sectional survey JF Quispe-Cañari, E Fidel-Rosales, D Manrique, J Mascaró-Zan, ... Saudi Pharmaceutical Journal 29 (1), 1-11	2021
COVID-19 cognitive deficits after respiratory assistance in the subacute phase: A COVID-rehabilitation unit experience F Alemanno, E Houdayer, A Parma, A Spina, A Del Forno, A Scatolini, ... Plos one 16 (2), e0246590	2021
The impact of pre-existing comorbidities and therapeutic interventions on COVID-19 LA Callender, M Curran, SM Bates, M Mairesse, J Weigandt, CJ Betts Frontiers in immunology 11, 1991	2020
Otolaryngological manifestations of hospitalised patients with confirmed COVID-19 infection M Özçelik Korkmaz, OK Eğilmez, MA Özçelik, M Güven European Archives of Oto-Rhino-Laryngology 278, 1675-1685	2021
The role of Neuropilin-1 in COVID-19 BS Mayi, JA Leibowitz, AT Woods, KA Ammon, AE Liu, A Raja PLoS Pathogens 17 (1), e1009153	2021
COVID-19 and acute sarcopenia C Welch, C Greig, T Masud, D Wilson, TA Jackson Aging and disease 11 (6), 1345	2020
Clinical evaluation of BD Veritor SARS-CoV-2 point-of-care test performance compared to PCR-based testing and versus the Sofia 2 SARS Antigen point-of-care test S Young, SN Taylor, CL Cammarata, KG Varnado, C Roger-Dalbert, ... Journal of clinical microbiology 59 (1), 10.1128/jcm. 02338-20	2020
COVID-19-associated neurological disorders: the potential route of CNS invasion and blood-brain barrier relevance A Achar, C Ghosh Cells 9 (11), 2360	2020
Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trial AA Abdelalim, AA Mohamady, RA Elsayed, MA Elawady, AF Ghallab American journal of otolaryngology 42 (2), 102884	2021
Headache associated with COVID-19: Frequency, characteristics and association with anosmia and ageusia PA Sampaio Rocha-Filho, JE Magalhães Cephalalgia 40 (13), 1443-1451	2020
ACE2: the molecular doorway to SARS-CoV-2 MM Medina-Enríquez, S Lopez-León, JA Carlos-Escalante, ... Cell & bioscience 10 (1), 1-17	2020
Neurological complications and infection mechanism of SARS-COV-2 D Wan, T Du, W Hong, L Chen, H Que, S Lu, X Peng Signal Transduction and Targeted Therapy 6 (1), 406	2021
Poor nutritional status, risk of sarcopenia and nutrition related complaints are prevalent in COVID-19 patients during and after hospital admission NJ Wierdsma, HM Kruizenga, LAML Konings, D Krebbers, JRMC Jorissen, ... Clinical nutrition ESPEN 43, 369-376	2021
Glutathione supplementation as an adjunctive therapy in COVID-19 V Guloyan, B Oganesian, N Baghdasaryan, C Yeh, M Singh, F Guilford, ... Antioxidants 9 (10), 914	2020
Antigen-based testing but not real-time PCR correlates with SARS-CoV-2 virus culture A Pekosz, CK Cooper, V Parvu, M Li, JC Andrews, YC Manabe, S Kodsi, ... MedRxiv, 2020.10. 02.20205708	2020
Viral infection and smell loss: The case of COVID‐19 I Glezer, A Bruni‐Cardoso, D Schechtman, B Malnic Journal of neurochemistry 157 (4), 930-943	2021

1 - 20

计算机程序会自动估算并确定日期和引用次数。